A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalised Covid-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. Zsolt Czegledi/AP A large WHO study suggests that the antiviral drug remdesivir did not help hospitalised coronavirus patients. The other drugs have largely been ruled out for Covid-19 by previous studies, but not remdesivir. READ MORE:* Covid-19: British breakthrough finds cheap drug improves survival rate* Coronavirus: Trump's 'game-changing' drug linked to increased risk of death, study says* A Covid-19 drug is 'proven' to work. However, Dr Andre Kalil, a University of Nebraska infectious disease specialist who helped lead the US remdesivir study, said the WHO one was poorly designed, which makes its conclusions less reliable.

Source: Stuff October 16, 2020 16:34 UTC